We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Feb 2023 - 09 Feb 2023

Blood Test for Protein Biomarker Could Detect Pancreatic Cancer at Very Early Stage

By LabMedica International staff writers
Posted on 02 Dec 2022
Print article
Image: A substance in the blood increases before diagnosis of pancreatic cancer (Photo courtesy of Pexels)
Image: A substance in the blood increases before diagnosis of pancreatic cancer (Photo courtesy of Pexels)

Pancreatic cancer initially produces only diffuse symptoms and is therefore often detected so late that it is difficult to treat successfully. As a result, the mortality rate for this form of cancer is very high. The only effective treatment at present is surgery. For it to be effective, the cancer must not have spread outside the pancreas. Finding ways to detect pancreatic cancer earlier would be an important step towards treating it before it is too late, and thus saving lives. Now, a new study has found that in some people diagnosed with pancreatic cancer, levels of a particular substance in their blood can be seen to start rising slowly as early as two years before the cancer was diagnosed. This raises the possibility for future research to find ways to detect the dreaded cancer earlier.

In the study, researchers at Umeå University (Umeå, Sweden) used the blood donated to the research by people in north of Sweden over several decades, and they are now showing that this is a research resource of a magnitude that has few equals in the world. There are already two known markers in the blood for pancreatic cancer, two proteins called CA19-9 and CEA, respectively. They are effective in monitoring the development of the cancer once it is established.

The researchers therefore systematically searched the biobank for people who later developed pancreatic cancer and measured markers in their blood that could show that the cancer was coming. What they found was that a small proportion of people who developed pancreatic cancer had slowly rising levels of the CA19-9 marker from two years before they were diagnosed with the cancer. However, the researchers were unable to find a marker that was sufficiently early to predict which healthy people were at risk of later developing the cancer. None of the markers they looked for was sensitive enough to be used for general population-level screening.

“The finding suggests that changes occur in the body even before symptoms of the disease make themselves known, said Daniel Öhlund,” Associate Professor at the Department of Radiation Sciences and one of the researchers behind the study.

“The study shows that with the right markers, it may be possible to detect pancreatic cancer earlier than we do today, and that would be very valuable,” added Malin Sund, Professor at the Department of Surgical and Perioperative Sciences, who led the work on the current study.

“There is potential for a blood test to detect pancreatic cancer at a very early stage, but that we need to find more sensitive markers for the disease than we currently have,” said James Mason, one of the study's lead authors.

Related Links:
Umeå University

Gold Supplier
STI Real-Time PCR Test
Neisseria Gonorrhoeae/Chlamydia Trachomatis/U.urealyticum Real-Time PCR Kit
Gold Supplier
Specimen Collection & Transport
Specimen Collection & Transport Devices
Borrelia/Rickettsia Real Time PCR Test
MutaPLEX Borrelia/Rickettsia Real Time PCR Kit
Western Blot Protein Analyzer

Print article



view channel
Image: Histopathology of Langerhans cell histiocytosis: The variation in nuclear contours of these cells is evident in this lesion. Classic `kidney bean` nuclei of Langerhans cells with a central groove are present (Photo courtesy of John Lazarchick, MD)

Cooperativity Between Myeloid Lineages Promotes Langerhans Cell Histiocytosis Pathology

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia seen in children and adults who present with lesions composed of pathologic variants of myeloid cells that share certain phenotypic... Read more


view channel
Image: Medical illustration of Carbapenem-resistant Enterobacteriacea (Photo courtesy of CDC, Stephanie Rossow)

Breakthrough Test Enables Targeted Antibiotic Therapy for Various Enterobacter Species

Bacteria of the Enterobacter genus are considered to be the most dangerous bacteria linked to hospital infections across the world. Some of their representatives demonstrate high resistance to commonly-used... Read more


view channel
Image: Flexible copper sensor made cheaply from ordinary materials (Photo courtesy of University of São Paulo)

Low-Cost Portable Sensor Detects Heavy Metals in Sweat

Heavy metals like lead and cadmium can be found in batteries, cosmetics, food and many other things that have become a part of daily life. However, they become toxic if they accumulate in the human body... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.